stars 1 stars 2 stars 3

Synergenz BioScience Ltd was formed in 2004 to commercialize discoveries about lung disease susceptibility first made by Dr. Robert P Young in research conducted at the University of Auckland in New Zealand. The Company licenses its core intellectual property and related marketing services in key markets around the world. The Company was originally spun off from Auckland University and backed by the Hong Kong-based Pacific Group Ltd. and its investment partners. Synergenz's research program continues in New Zealand and in collaboration with leading investigators, licensees and commercial partners around the world.Synergenz BioScience, Inc., located in Evanston, Illinois has been established to provide marketing services.

Synergenz Bioscience Ltd Questions

Synergenz Bioscience Ltd is based in Evanston, Illinois.

The NAICS codes for Synergenz Bioscience Ltd are [81321, 813, 8132, 81, 813212].

The SIC codes for Synergenz Bioscience Ltd are [839, 83].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users